China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)

Lung cancer is the leading cause of cancer-related death in China. The results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality. The aim of tihs study is to establish the China Natio...

Full description

Saved in:
Bibliographic Details
Published in:Zhongguo fei ai za zhi 2018-02, Vol.21 (2), p.67-75
Main Authors: Zhou, Qinghua, Fan, Yaguang, Wang, Ying, Qiao, Youlin, Wang, Guiqi, Huang, Yunchao, Wang, Xinyun, Wu, Ning, Zhang, Guozheng, Zheng, Xiangpeng, Bu, Hong, Li, Yin, Wei, Sen, Chen, Liang'an, Hu, Chengping, Shi, Yuankai, Sun, Yan
Format: Article
Language:Chinese
Subjects:
Aged
Biomarkers
CAD
China - epidemiology
Computer aided design
Early Detection of Cancer
Female
Guideline
Health risk assessment
High risk population
Humans
LDCT
Lung cancer
Lung neoplasms
Lung Neoplasms - diagnostic imaging
Lung Neoplasms - epidemiology
Male
Mass Screening
Medical diagnosis
Medical imaging
Medical screening
Middle Aged
Mortality
Patient Selection
Practice Guidelines as Topic
Prostate
Radiation Dosage
Risk
Rural Population - statistics & numerical data
Screening
Smoking cessation
Studies
Surgery
Task forces
Thoracic surgery
Tomography
Tomography, Spiral Computed
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lung cancer is the leading cause of cancer-related death in China. The results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality. The aim of tihs study is to establish the China National lung cancer screening guidelines for clinical practice. The China lung cancer early detection and treatment expert group (CLCEDTEG) established the China National Lung Cancer Screening Guideline with multidisciplinary representation including 4 thoracic surgeons, 4 thoracic radiologists, 2 medical oncologists, 2 pulmonologists, 2 pathologist, and 2 epidemiologist. Members have engaged in interdisciplinary collaborations regarding lung cancer screening and clinical care of patients with at risk for lung cancer. The expert group reviewed the literature, including screening trials in the United States and Europe and China, and discussed local best clinical practices in the China. A consensus-based guidelines, Chin
ISSN:1009-3419
1999-6187
DOI:10.3779/j.issn.1009-3419.2018.02.01